Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
Int J Mol Sci
; 23(7)2022 Mar 24.
Article
in En
| MEDLINE
| ID: mdl-35408919
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
Immunoconjugates
Limits:
Female
/
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2022
Type:
Article
Affiliation country:
Italy